325
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression.

      Nature genetics
      Amino Acid Sequence, Animals, Antimicrobial Cationic Peptides, genetics, Bone Morphogenetic Protein 2, Bone Morphogenetic Proteins, metabolism, CHO Cells, Cricetinae, GPI-Linked Proteins, Gene Expression Regulation, physiology, Hepcidins, Humans, Liver, cytology, Membrane Proteins, Molecular Sequence Data, Mutation, Polymerase Chain Reaction, Signal Transduction, Transforming Growth Factor beta

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Hepcidin is a key regulator of systemic iron homeostasis. Hepcidin deficiency induces iron overload, whereas hepcidin excess induces anemia. Mutations in the gene encoding hemojuvelin (HFE2, also known as HJV) cause severe iron overload and correlate with low hepcidin levels, suggesting that hemojuvelin positively regulates hepcidin expression. Hemojuvelin is a member of the repulsive guidance molecule (RGM) family, which also includes the bone morphogenetic protein (BMP) coreceptors RGMA and DRAGON (RGMB). Here, we report that hemojuvelin is a BMP coreceptor and that hemojuvelin mutants associated with hemochromatosis have impaired BMP signaling ability. Furthermore, BMP upregulates hepatocyte hepcidin expression, a process enhanced by hemojuvelin and blunted in Hfe2-/- hepatocytes. Our data suggest a mechanism by which HFE2 mutations cause hemochromatosis: hemojuvelin dysfunction decreases BMP signaling, thereby lowering hepcidin expression.

          Related collections

          Author and article information

          Comments

          Comment on this article